Non-Hodgkin Lymphoma (BCGSC, Nature 2011)

Summary

Non-Hodgkin Lymphoma (BCGSC, Nature 2011) is a study catalogued by cBioPortal DataHub under the cancer-type code nhl. EvidenceHelix groups it with blood, lymph and bone marrow studies.

Study description

Whole genome or whole exome sequencing of 14 NHL tumors and their matched normals.

Text as published in the source's study metadata.

Citation & PubMed

Morin et al. Nature 2011

Linked PubMed records: PMID 21796119

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

nhl_bcgsc_2011

Short name

NHL (bcgsc 2011)

Source cancer-type code

nhl

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Morin et al. Nature 2011

• PubMed record 21796119 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Cutaneous T Cell Lymphoma (Columbia U, Nat Genet 2015)

  Whole-Exome Sequencing (WXS) of tumor-normal sample pairs from 25 patients with Sezary Syndrome and 17 patients with other Cutaneous T Cell Lymphoma (CTCLs).

  Blood, lymph and bone marrowOther published and consortium studiesSource code nhlPubMed 1

• Diffuse Large B-cell Lymphoma (BCGSC, Blood 2013)

  Whole genome sequencing of 40 DLBCL tumor/normal pairs and 13 cell lines.

  Blood, lymph and bone marrowOther published and consortium studiesSource code nhlPubMed 1

• Diffuse Large B-Cell Lymphoma (Broad, PNAS 2012)

  Whole exome sequencing of 58 primary DLBCL samples and their matched normals.

  Blood, lymph and bone marrowOther published and consortium studiesSource code nhlPubMed 1

• Primary Central Nervous System Lymphoma (Mayo Clinic, Clin Cancer Res 2015)

  Exome sequencing of 19 immunocompetent primary central nervous system lymphoma (PCNSL) samples.

  Blood, lymph and bone marrowOther published and consortium studiesSource code nhlPubMed 1

• Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2015)

  Comprehensive profiling of infant MLL-rearranged acute lymphoblastic leukemia (MLL-R ALL)

  Blood, lymph and bone marrowOther published and consortium studiesSource code bllPubMed 1

• Acute Lymphoblastic Leukemia (St Jude, Nat Genet 2016)

  Whole-genome and/or whole-exome sequencing of ERG-altered B-ALL tumor/normal pairs.

  Blood, lymph and bone marrowOther published and consortium studiesSource code bllPubMed 1

• Acute Myeloid Leukemia (OHSU, Cancer Cell 2022)

  Whole-exome and transcriptomic sequencing of 942 acute myeloid leukemia samples (with 500 matched normals) from the Beat AML program.

  Blood, lymph and bone marrowOther published and consortium studiesSource code amlPubMed 1

• Acute Myeloid Leukemia (OHSU, Nature 2018)

  Whole-exome sequencing of 672 acute myeloid leukemia samples (with 454 matched normals) from the Beat AML program.

  Blood, lymph and bone marrowOther published and consortium studiesSource code amlPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.